Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Aug 21, 2023 7:26pm
73 Views
Post# 35598925

RE:RE:Response to fuzzy, and for everybody else, too

RE:RE:Response to fuzzy, and for everybody else, tooWouldn't being sued be interesting, eh, fuzzy? I'd get to look at the communications between everybody.

So, I take it that you are now supporting Rathjen. Good for you. She needs a friend, even one like you.

I will be getting far more agressive, fuzzy. I'm already making a good case, whether you can understand the nuances of the case or not. And everything I'm saying is interpretation of publicly disclosed information. It's not a solid case, fuzzy. It's not being presented as one. It's amazing how much can discerned from 460 pages of public filings. But my guess is that you don't have the bandwidth for it.

Anyway, maybe you should give your own interests a thought. For instance, how much would you take to forget about voting against a buyout? 

jd
<< Previous
Bullboard Posts
Next >>